Pharma companies to invest Rs 700 crore in Hyderabad

Granules India has manufacturing sites in eight locations and presence in 75 countries across the globe.

93
Medicines
Picture: Pixabay

HYDERABAD: Pharmaceutical companies Granules India and Laurus Labs are all set to invest in Genome Valley in Hyderabad. Representatives of the two companies met Industries Minister KT Rama Rao on Tuesday and announced their investment plans.

Granules India, a Hyderabad based pharmaceutical company, has announced a major investment of Rs 400 crore to set up a manufacturing facility with a capacity to manufacture 10 billion units of finished dosages. The proposed unit will generate employment for about 1,600 people.

Granules India has manufacturing sites in eight locations and presence in 75 countries across the globe. The company already operates the world’s largest Commercial Pharmaceutical Formulation Intermediates (PFI) Facility at Gagillapur near Hyderabad.

Krishna Prasad Chigurupati, chairman and managing director of Granules India Ltd, met IT and Industries Minister KT Rama Rao at Pragathi Bhavan and formally announced their investment plans.

In a related development, Laurus Labs, a leading research driven pharmaceutical company, has announced the setting up of a formulation facility with a unit capacity of 5 billion. The company plans to invest Rs 300 crore in two phases of Rs 150 crore each. Phase one of the plant is expected to provide employment to about 150 people.


Also read: Beneficial for Indian drug exporters: Panama’s New tax regime


Satyanarayana Chava, CEO, Laurus Labs, met Industries Minister Rama Rao on Tuesday, along with his team before making this announcement. Industries Department Principal Secretary Jayesh Ranjan was also present in the meeting.

Laurus Labs has its R&D facility in IKP Knowledge Park, Hyderabad, and also operates six manufacturing facilities in Visakhapatnam in Andhra Pradesh. All these facilities have been certified and approved by WHO, USFDA, NIP Hungary, and other renowned agencies.

Laurus Labs is one of the leading manufacturers of API for Anti-Retroviral (ARV), Oncology, Cardio-vascular, Anti-Diabetics, Anti-Asthma and Gastroenterology.

Industries Minister Rama Rao thanked the leadership of both Granules India and Laurus Labs for choosing to invest in Telangana. He said the Telangana government will provide all possible support to both these companies.

The minister said the proactive policies of the state government under the leadership of Chief Minister K Chandrasekhar Rao are attracting global leaders in IT, Pharma, Textiles, Aerospace and Defence and other sectors to Hyderabad and other parts of Telangana. He expressed confidence that these investments in the manufacturing sector will provide much needed employment to local youth from Telangana.


The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.